API Holdings is India’s largest digital healthcare platform (based on GMV of products and services sold for the year ended March 31, 2021), according to RedSeer Report. API Holdings operate as an integrated, end-to-end business that aims to provide solutions for healthcare needs of consumers across the following critical stages
A. providing digital tools and information on illness and wellness,
B. offering teleconsultation,
C. offering diagnostics and radiology tests, and
D. delivering treatment protocols including products and devices.
API Holdings has custom-built proprietary technology, unified data platforms, supply chain capabilities, and deep understanding of the dynamic interplay between the various sub-segments of India’s healthcare market are the capabilities that differentiate them.
These capabilities enable them to provide each stakeholder in the healthcare value-chain, viz.:
(a) channel (wholesalers, retailers and chemists / institutions),
(b) consultants (and hospitals), diagnostic and radiology labs,
(c) consumers, and
(d) companies (pharmaceutical, nutraceutical, medical devices)
with the technology tools and capabilities to solve their challenges, while also enabling them to benefit from an interconnected network. At the same time, they also enable them to build a scaled presence, allowing their platform to reach a wide base of stakeholders across the length and breadth of this country. Their businesses have a presence across the country, with last-mile 163 capabilities to deliver in over 18,587 pin codes (for June 2021) via PharmEasy marketplace, allowing them the ability to provide access in an affordable manner to the common man. Their platforms have scaled across urban, semi-urban and rural India, with an ability to serve people across income groups and geographies.
Source: PharmEasy IPO DRHP
Source: PharmEasy IPO DRHP
Source: PharmEasy IPO DRHP
Pharmeasy:
PharmEasy is a consumer healthcare “super app”.
PharmEasy is a consumer healthcare “super app” that provides consumers with on-demand, home delivered access to a wide range of prescription, OTC pharmaceutical, other consumer healthcare products, comprehensive diagnostic test services, and teleconsultations thereby serving their healthcare needs.
25 Million+Total Users
8.8 million+Total Orders
2.4 million+Transacting Customers
Services:
Order Medicines
Healthcare Products
Diagnostic Tests
Source: PharmEasy IPO DRHP
Key Parameters of PharmEasy Rights Issue indicated by the company:
Know more about API Holdings (PharmEasy) Rights Issue in detail by reading our blog post here.
| Name | API Holdings Limited Unlisted Shares |
|---|---|
| Alias Name | PharmEasy Unlisted Shares |
| Face Value | ₹ 1 |
| ISIN Code | INE0DJ201029 |
| Available in Depository | CDSL & NSDL |
| Pharmeasy Unlisted Share Price | ₹ 28.50 Per Share |
| Lot Size | 500 Shares |
| PAN | AASCA1201E |
| Particulars | 2021-22 | 2020-21 | 2019-20 |
|---|---|---|---|
| Revenue from operations | 57,288.21 | 23,352.69 | 6,675.42 |
| Other income | 521.81 | 253.93 | 699.06 |
| Total income | 57,810.02 | 23,606.62 | 7,374.48 |
| Cost of materials consumed | 854.60 | - | - |
| Purchase of stock-in-trade | 52,566.12 | 22,668.17 | 6,991.24 |
| Changes in inventories of stock-in-trade | (2,290.53) | (1,143.95) | (582.38) |
| Employee benefits expense | 14,589.71 | 2,702.94 | 1,371.90 |
| Finance costs | 2,582.64 | 434.31 | 118.86 |
| Depreciation and amortisation expense | 1,587.85 | 329.01 | 187.71 |
| Other expenses | 15,025.51 | 4,818.80 | 2,756.71 |
| Total expenses | 84,915.90 | 29,809.28 | 10,844.04 |
| Loss before tax | (39,707.70) | (6,202.66) | (3,469.56) |
| Loss after tax | (39,924.96) | (6,413.36) | (3,352.79) |
| EPS (In INR) | (7.28) | (2.67) | (1.29) |
*Rates mentioned in the chart are indicative.
The trend indicator above has been derived from the current demand/supply of PharmEasy Unlisted Shares. The trend has a tendency to change anytime depending on the market conditions and other events. This indicator must not be construed as any recommendation to buy/sell/hold.
Total Number of Outstanding Shares: 6,142,041,070
Market Cap Scenarios:
At 30 Rs/Share, PharmEasy Unlisted Shares values the company at approx. Rs. 18,426 crores.
This are just pre-defined scenarios, since the market cap is variable to price, you can calculate the latest market cap based on the ongoing rates of pharmeasy unlisted shares.
At 35 Rs/Share, PharmEasy Unlisted Shares values the company at approx. Rs. 21,497 crores.
This are just pre-defined scenarios, since the market cap is variable to price, you can calculate the latest market cap based on the ongoing rates of pharmeasy unlisted shares.
At 40 Rs/Share, PharmEasy Unlisted Shares values the company at approx. Rs. 24,568 crores.
This are just pre-defined scenarios, since the market cap is variable to price, you can calculate the latest market cap based on the ongoing rates of pharmeasy unlisted shares.
At 45 Rs/Share, PharmEasy Unlisted Shares values the company at approx. Rs. 27,639 crores.
This are just pre-defined scenarios, since the market cap is variable to price, you can calculate the latest market cap based on the ongoing rates of pharmeasy unlisted shares.
At 50 Rs/Share, PharmEasy Unlisted Shares values the company at approx. Rs. 30,710 crores.
This are just pre-defined scenarios, since the market cap is variable to price, you can calculate the latest market cap based on the ongoing rates of pharmeasy unlisted shares.
At 55 Rs/Share, PharmEasy Unlisted Shares values the company at approx. Rs. 33,781 crores.
This are just pre-defined scenarios, since the market cap is variable to price, you can calculate the latest market cap based on the ongoing rates of pharmeasy unlisted shares.
At 60 Rs/Share, PharmEasy Unlisted Shares values the company at approx. Rs.36,852 crores.
This are just pre-defined scenarios, since the market cap is variable to price, you can calculate the latest market cap based on the ongoing rates of pharmeasy unlisted shares.
Source: PharmEasy IPO DRHP
Other Shareholders includes key shareholders & public
| Name | Listing Status |
|---|---|
| Tata 1mg | Unlisted |
| Netmeds | Unlisted |
| Apollo Hospitals (Apollo Pharmacy) | Listed |
No information found for API Holdings (PharmEasy) Dividend
API Holdings (PharmEasy) Rights Issue
No information found for API Holdings (PharmEasy) Buyback
API Holdings (PharmEasy) shares face value split:
Review date: September 23, 2022
Unlisted Shares Price at the time of review: Rs.36 per equity share.
Disclaimer: Please note that the above review is about the API Holdings (PharmEasy) Unlisted Shares trading in the unlisted space and not about the company itself. The views are purely personal and must not be construed as any recommendation/advice to buy/sell/hold. The figures and calculations are presented in good faith and we are not liable for any errors in the same. Kindly do your due diligence before investing.
Process of Buying PharmEasy Unlisted Shares
For detailed buying process, refer here
The minimum lot size for investing in PharmEasy Unlisted Shares is 500 Shares
The Lock-in period for PharmEasy Unlisted Shares will be Six Months. The Lock-in period starts from the date of IPO allotment. (According to DRHP)
As per the SEBI guidelines, lock-in period for Pre IPO shares is six months. The lock-in period starts from the date of allotment of IPO. During the lock-in period, the shares remain in your account but are marked as locked. After six months, the shares automatically gets unlocked and one can sell it normally on stock exchanges like any other listed shares
Yes, buying PharmEasy Unlisted Shares is completely legal
You can regularly check the updated price of PharmEasy Unlisted Shares at our Website and on our Telegram Channel
The IPO of PharmEasy (API Holdings Limited) can be expected in medium to long term.
At Unlisted Arena, you can buy PharmEasy Unlisted Shares and many such Pre IPO Shares easily at most reasonable rates with a hassle-free process. Unlisted Arena is India’s leading dealer in Unlisted & Pre IPO Shares
You can sell PharmEasy Unlisted Shares:
Before IPO: You can sell PharmEasy Unlisted Shares before IPO too. You need to have a buyer for this shares. We can also help you to liquidate your holdings of unlisted shares.
After IPO: Once the lock-in period is complete, you can sell the shares on stock exchanges(NSE/BSE) just like any other listed shares.
There are two methods to transfer PharmEasy Unlisted Shares
Method 1 – Offline Transfer
In this method, you must have a Delivery Instruction Slip (DIS) book which is provided by your broker. All the demat broking companies have its own DIS book. Along with DIS, there is an annexure which is to be submitted by the seller. Annexure too is provided by the demat broking company. After filing DIS and annexure, duly signed by the seller, they are to be handed over to your respective broker. Post that, your broker will process the request and transfer the shares as per details provided
Method 2 – Online Transfer
One can also transfer shares online through E-DIS/Off Market share transfer. The client must check with their respective brokers if they provide such facility. One can also transfer shares through CDSL easiest (for CDSL Demat) and NSDL Speed-E (For NSDL Demat) after registering into it.
Yes, API Holdings Unlisted Shares are in demat form just like listed shares. You can buy and store them in your demat account. Like listed shares, Unlisted Shares also have their ISIN code so that you can verify the authenticity of shares.
Once the process is complete, PharmEasy Unlisted Shares will reflect in your demat account. The shares usually gets reflected in your Depository holdings (DP Holdings). You can check it in your stock brokers app/website. The shares are also shown on your DP transactions and holding statement.
You can also check your holdings in the following:
If you have CDSL Demat Account – CDSL Myeasi app
If you have NSDL Demat Account – NSDL Speed-E
Many investors do ask ‘How to buy PharmEasy Unlisted Shares in Zerodha, Angel One, Upstox, etc?’
You can buy PharmEasy Unlisted Shares in any demat account with any broking company
When it comes to delivery of unlisted shares- Be assured as Unlisted Arena is the fastest in delivering shares. Once the process is completed, we usually deliver the shares on same day or the next working day. i.e T day or (T+1) working day.
Short Term Capital Gains Tax: If unlisted shares are sold in 24 months or less, gains from such sale are taxed at the slab rate.
Long Term Capital Gains Tax: If unlisted shares are sold after holding for more than 24 months, gains on such sale will be taxed at 20% after indexation.
Tax on Capital Gains on Unlisted Shares that are sold after getting listed: The tax rates will be the same as that on purchase and sale of listed shares.
That is, the long-term gains (shares sold after holding for more than one year) will be taxed at 10% after a threshold of ₹ 1 lakh per financial year.
Short-term gains (gains on selling shares in one year or less) will be taxed at 15%
For listed shares, there are numerous applications and website which shows the market capitalization of shares. But no need to worry, we have included market capitalization scenarios on our website which shows market cap/valuations of the company based on prevailing Unlisted Shares rates. In addition, we have also mentioned total number of shares so that you can easily calculate current market cap quickly without putting much efforts. Click here to see the valuations of PharmEasy Pre IPO shares
Quick tip: Market Cap= Total Outstanding shares x Price per share
You can easily check latest developments, news related to PharmEasy Unlisted Shares on our website without any sign up or login. Click here to know about latest news and happenings
Unlisted Arena is a prominent name which facilitates Unlisted Shares & Pre IPO Shares safely and securely. All the transactions are done through bank accounts where no third parties are involved. Unlisted Arena always quotes transparent rates and is also known for its fastest delivery of Unlisted Shares and Pre IPO Shares. Unlisted Arena gets featured regularly in India’s top most financial publications. You can check media coverage of Unlisted Arena here
API Holdings is a Pre IPO company. API Holdings had plans to get its stock listed on exchanges. For that purpose, API Holdings had filed its IPO DRHP with SEBI
Yes, NRIs can also buy and sell PharmEasy Unlisted Shares just like domestic investors. But their investment is on a non-repatriable basis
Like any listed shares, Unlisted Shares price is also determined by demand-supply of Unlisted Shares. Higher the demand, higher the price and vice-versa. The rates of Unlisted Shares are also derived from its performance, corporate actions such as declaration of results, bonus, dividend, etc. Another important aspect is share price/valuation of its listed peer. If the listed business is identical, unlisted companies share price/valuation will too be in similar fashion
At Unlisted Arena, we charge Zero Brokerage/Charges. The rates quoted by us are- net rates, i.e., you do not need to pay any brokerage or charges
One can buy PharmEasy Unlisted Shares in any demat account – no matter with which broker you have a demat account. There is no need for separate/special demat account for buying Unlisted Shares.
Unlisted Arena sources API Holdings Unlisted Shares from existing investors looking to liquidate their investment
Yes, you are eligible to get dividend, bonus and/or any other corporate actions declared by the company. You need to hold the Unlisted Shares in your demat account on the record date declared by the company to be eligible for such corporate actions
PharmEasy Video:
Copyright 2022 @ Unlisted Arena. All rights reserved.
